Speaker
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Xingfeng Bao, Senior Vice President & Head of Research at GV20 Therapeutics LLC, is speaking at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Panel Discussion: How to Overcome the Biological Barriers Limiting Deep & Durable Immune Reset”.
27–29 Oct 2026Boston, United States of America
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Chief Scientific Advisor & Chairman of Scientific Advisory Board, Cullinan Therapeutics, Inc.
Chief Business Officer, NovalGen
Co-Founder, CEO & President, Reverb Therapeutics Inc.
Program Director, Hanson Wade
Chief Research Officer & Co-Founder, 3T Biosciences
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Xingfeng Bao, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].